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Abstract
Objective: To investigate the significance of cellular immune markers, as well as that of collagen and elastic 
components of the extracellular matrix, within granulomatous structures in biopsies of patients with pulmonary 
or extrapulmonary sarcoidosis. Methods: We carried out qualitative and quantitative evaluations of inflammatory 
cells, collagen fibers, and elastic fibers in granulomatous structures in surgical biopsies of 40 patients with 
pulmonary and extrapulmonary sarcoidosis using histomorphometry, immunohistochemistry, picrosirius red 
staining, and Weigert’s resorcin-fuchsin staining. Results: The extrapulmonary tissue biopsies presented 
significantly higher densities of lymphocytes, macrophages, and neutrophils than did the lung tissue biopsies. 
Pulmonary granulomas showed a significantly higher number of collagen fibers and a lower density of elastic 
fibers than did extrapulmonary granulomas. The amount of macrophages in the lung samples correlated with 
FVC (p < 0.05), whereas the amount of CD3+, CD4+, and CD8+ lymphocytes correlated with the FEV1/FVC ratio 
and VC. There were inverse correlations between TLC and the CD1a+ cell count (p < 0.05), as well as between 
DLCO and collagen/elastic fiber density (r = −0.90; p = 0.04). Conclusions: Immunophenotyping and remodeling 
both showed differences between pulmonary and extrapulmonary sarcoidosis in terms of the characteristics of 
the biopsy samples. These differences correlated with the clinical and spirometric data obtained for the patients, 
suggesting that two different pathways are involved in the mechanism of antigen clearance, which was more 
effective in the lungs and lymph nodes.
Keywords: Sarcoidosis; Granulomatous disease, chronic; Extracellular matrix; Immunophenotyping; 
Respiratory function tests.
Resumo
Objetivo: Investigar o significado de marcadores de imunidade celular e de componentes elásticos/colágeno 
da matriz extracelular em estruturas granulomatosas em biópsias de pacientes com sarcoidose pulmonar 
ou extrapulmonar. Métodos: Determinações qualitativas e quantitativas de células inflamatórias, de fibras 
de colágeno e de fibras elásticas em estruturas granulomatosas em biópsias cirúrgicas de 40 pacientes com 
sarcoidose pulmonar e extrapulmonar foram realizadas por histomorfometria, imuno-histoquímica, e técnicas 
de coloração com picrosirius e resorcina-fucsina de Weigert. Resultados: A densidade de linfócitos, macrófagos 
e neutrófilos nas biópsias extrapulmonares foi significativamente maior do que nas biópsias pulmonares. Os 
granulomas pulmonares apresentaram uma quantidade significativamente maior de fibras de colágeno e menor 
densidade de fibras elásticas que os granulomas extrapulmonares. A quantidade de macrófagos nos granulomas 
pulmonares correlacionou-se com CVF (p < 0,05), ao passo que as quantidades de linfócitos CD3+, CD4+ e 
CD8+ correlacionaram-se com a relação VEF1/CVF e com CV. Houve correlações negativas entre CPT e contagem 
de células CD1a+ (p < 0,05) e entre DLCO e densidade de fibras elásticas/colágenas (r = −0,90; p = 0,04). 
Conclusões: A imunofenotipagem e o remodelamento apresentaram características diferentes nas biópsias 
dos pacientes com sarcoidose pulmonar e extrapulmonar. Essas diferenças correlacionaram-se com os dados 
clínicos e espirométricos dos pacientes, sugerindo que há duas vias envolvidas no mecanismo de depuração de 
antígenos, que foi mais eficaz nos pulmões e linfonodos.
Descritores: Sarcoidose; Doença granulomatosa crônica; Matriz extracelular; Imunofenotipagem; Testes de 
função respiratória.
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took deep breaths in the supine position; for 
the last 10 cm of the caudal part of the lungs, 
the scans were taken at 2-3 cm intervals, with 
the patients in the prone position. Two thoracic 
radiologists prospectively and independently 
examined all of the lobes on the HRCT scans 
for micronodules, opacity, and lymphadenopathy 
(Table 1).
For all of the patients with pulmonary 
sarcoidosis, we collected data on the history of 
smoking and pulmonary function parameters 
(FVC, FEV1, FEV1/FVC ratio, RV, TLC, and single-
breath DLCO). We also collected the scores on 
a six-point dyspnea scale routinely applied to 
patients treated at our institution, the scores 
ranging from 0 (no dyspnea) to 6 (very severe 
dyspnea).(16)
Staining of collagen fibers was performed with 
a 0.2% solution of Sirius red (Direct Red 80, CI 
35780; Aldrich, Milwaukee, WI, USA) dissolved in 
aqueous saturated picric acid. This dye has been 
widely used for staining collagen in histological 
specimens and allows the quantitative analysis of 
collagen in paraffin sections.(11,17) The enhancement 
of collagen birefringence by picrosirius red staining 
and polarized light microscopy is specific for all 
collagen structures consisting of aggregates of 
oriented molecules. Elastic fiber staining was 
performed with the Weigert’s resorcin-fuchsin 
method, after oxidation.(18) This method allows 
selective identification of the three types of elastic 
fibers (oxytalan, elaunin, and fully developed 
elastic fibers).
The primary antibodies used in the present 
study were mouse monoclonal antibodies (Dako, 
Glostrup, Denmark; for all):
• mouse anti-human CD68, clone KP1 (M0814; 
dilution, 1:3,200), a marker for macrophages/
histiocytes
• mouse anti-human neutrophil elastase, 
clone NP57 (M0752; dilution, 1:800)
• anti-human CD3 (dilution, 1:600), CD4 
(dilution, 1:400), CD8 (dilution, 1:100), 
CD20 (dilution, 1:600), CD1a (dilution, 
1:20), and S100 (dilution, 1:600), all of 
which are markers for T and dendritic cells
For the tests, the streptavidin-biotin complex 
method was used.(14,19)
Immune cells were quantified by a conventional 
stereological method, i.e., the point sampled 
intercept method.(20) At a magnification of ×400, 
8-10 granulomatous structures were evaluated by 
Introduction
Sarcoidosis is a systemic granulomatous disease 
of unknown etiology. The diagnosis is based on 
clinical, radiographic, and pathological findings. 
Most patients generally have favorable clinical 
courses.(1) Although pulmonary and extrapulmonary 
parenchymal involvement improves spontaneously 
in most patients, progression to fibrosis, leading 
to permanent functional impairment, occurs in 
20-25%, and death occurs in 5-10%.(2,3) In this 
context, a large number of clinical, physiological, 
and radiographic parameters have been investigated 
in order to evaluate the outcome of sarcoidosis.(4-8)
The disease activity is marked by the process 
of extracellular matrix (ECM) remodeling—
which involves the balance between immune 
cells and tissue remodeling(9,10)—the impact of 
histopathological staging on the prognosis of 
sarcoidosis having never been investigated.
Because cellular immune phenomena and ECM 
remodeling have been shown to be promising 
prognostic markers in diffuse interstitial lung 
disease,(11-14) we hypothesized that the two have a 
similar impact on the prognosis of sarcoidosis. We 
reviewed medical records and pathology reports 
over a period of 10 years in order to investigate 
the significance of cellular immune markers, as 
well as that of collagen and elastic components 
of the ECM, within the granulomatous structures 
found in biopsies of patients with pulmonary 
or extrapulmonary sarcoidosis.(15)
Methods
The study group comprised 40 patients who 
had been diagnosed with sarcoidosis on the 
basis of clinical and histological criteria.(1) The 
tissue samples examined included pulmonary 
parenchymal and bronchial biopsy specimens 
(in 25 patients), mediastinal or peripheral lymph 
nodes (in 8 patients), liver (in 4 patients), and 
skin (in 3 patients).
The medical records were reviewed, and the 
date of the biopsy was used as the date of 
diagnosis. Information regarding patient gender, 
patient age, and the treatment given was collected. 
The patients with pulmonary sarcoidosis were in 
the early stage of the disease and underwent lung 
biopsy as part of their initial clinical evaluation. 
Cardiac parameters were normal in those patients, 
and chest HRCT scans (1.0- or 1.5-mm-thick slices) 
were taken at 1-cm intervals while the patients 
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systematic point counting, an eyepiece micrometer 
and a sampling grid with 100 points and 50 lines 
having been used in order to count the number 
of points overlying positively stained cells.
Collagen and elastic fibers were quantified 
by image analysis. The image analysis system 
consisted of an Olympus camera coupled to an 
Olympus microscope (Olympus Optical, Tokyo, 
Japan), which transmitted the images to a computer 
equipped with a Pentium 1,330-MHz processor 
(Intel Corporation, Santa Clara, CA, USA) and a 
monitor (LG Electronics Brasil, Manaus, Brazil) 
by means of a digitizing system (Oculus TCX; 
Coreco Inc., St. Laurent, Quebec, Canada). The 
images were processed using the program Image 
Pro-Plus, version 6.0 (Media Cybernetics Inc., 
Bethesda, MD, USA). For each tissue specimen, 
a range of 8-10 granulomatous structures were 
analyzed at ×400 magnification. The density of 
collagen and elastic fibers was measured and 
expressed as a ratio between the quantity of 
fibers and the total area studied. The final results 
express the area occupied by the various collagen 
and elastic fibers in relation to the total area.(21)
One-way ANOVA was used in order to analyze 
the variation in the mean number of immune 
cells, collagen fibers, and elastic fibers, as well 
as the distribution of immune cells, collagen 
fibers, and elastic fibers within granulomas in the 
various organ tissues. The means were compared, 
a priori, by Levene’s test for homogeneity of 
variance, followed by post hoc analysis with 
the Bonferroni test for multiple comparisons (in 
case of homogeneity of variance) or Dunnett’s 
T3 test (in case of heterogeneity of variance). In 
addition, a paired t-test and the general linear 
model were used in order to test the relationships 
among continuous variables, and the residuals 
were examined to ensure that they had an 
approximately normal distribution. All of the 
analyses were carried out with the Statistical 
Package for the Social Sciences, version 18.0 
(SPSS Inc., Chicago, IL, USA). The threshold for 
statistical significance was set at p < 0.05.
Results
Table 1 lists the characteristics of the 40 
patients included in the study, i.e., 16 males 
and 24 females, the mean age being 48 years 
(range, 26-83 years). Of the 40 patients, 11 were 
Black. Most of the 25 patients with pulmonary 
sarcoidosis showed a restrictive pattern or an 
Table 1 - Characteristics of the patients.a
Characteristic Result
(n = 40)
Age, yearsb 48 (26-83)
Gender, Male/Female 16/24
Race, n
White 9
Black 11
No data 20
Type of sarcoidosis
Pulmonary 25
Extrapulmonary 15
Lymph node 8
Liver 4
Skin 3
Treatment with steroids
Yes 27
No 13
Symptoms
Dyspnea 25
Mild 21
Moderate 2
Severe 2
Cough
Yes 18
No 7
Fever
Yes 15
No 10
Weight loss
Yes 12
No 13
Headache
Yes 6
No 19
Erythema nodosum
Yes 7
No 18
Gastrointestinal symptoms
Yes 6
No 19
Comorbidities
Yes 20
No 5
Smoking history
Yes 15
No 10
CT findings, n/N
Opacities 2/25
Micronodules 21/25
Consolidation 2/25
Spirometric parameters, % of predicted
FVC 77.26
FEV1 74.00
TLC 93.20
DLCO 64.16
aValues expressed in n, except where otherwise indicated. 
bValue expressed as mean (range).
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lymphocytes, in all of the patients. Staining for 
fungi and AFB gave negative results. In all of 
the patients with extrapulmonary sarcoidosis, 
the granulomas were characterized by severe 
architectural remodeling and variable amounts 
of fibrous tissue. In particular, the cortical and 
obstructive pattern, and 15 were current or 
former smokers. Twenty-seven patients received 
corticosteroid therapy.
Histological examination revealed noncaseating 
granulomas (Figure 1), composed of multinucleated 
giant cells, epithelioid cells, macrophages, and 
Figure 1 - Lung, lymph node, liver, and skin tissue samples stained with H&E, picrosirius red (collagen), and 
Weigert’s resorcin-fuchsin (elastic fibers). Note architectural distortion in the lung, lymph node, liver, and skin 
samples (H&E staining), a diffuse increase in the birefringence of collagen fibers (picrosirius red staining), 
and a low amount of elastic fibers in the granulomas (Weigert’s resorcin-fuchsin stain). In decreasing order, 
similar distortions are observed in the lung, lymph node, liver, and skin tissue samples (magnification, ×200).
Immunophenotyping and extracellular matrix remodeling  
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Table 2 - Summary of morphometric results.a
Parameter Lung Lymph node Liver Skin Extrapulmonary (total)
CD4 7.48 16.89 10.08 8.18 11.71
CD8 5.03 14.92 12.10 4.57 10.53
CD3 7.73 20.36 11.81 12.37 14.84
CD20 2.75 11.38 1.51 2.72 5.20
CD1a 0.36 0.28 0.10 1.95 0.77
S100 1.10 1.83 1.71 1.68 1.74
CD68 9.64 19.22 12.08 11.27 14.19
Elastase 0.40 1.30 2.71 1.35 1.78
Collagen 25.62 15.08 6.30 5.15 8.84
Elastic fiber 3.75 48.39 49.82 29.79 42.66
aThe units of “% of points” indicate the number of points overlying the phenomenon of interest divided by the total 
number of points overlying the tumor. In morphometry, this is called a point fraction and is often symbolized as Pp, 
which has been shown to approximate the volume fraction.(21)
medullary areas of the lymph nodes were mostly 
replaced by epithelioid and sclerosing granulomas 
that were peripherally surrounded by lymphocytes.
Figure 1 shows granulomas stained with 
picrosirius and viewed under polarized light. 
The granulomas in the samples obtained from 
the patients with extrapulmonary sarcoidosis 
showed a homogeneous orange-red birefringence, 
coincident with minor distortions of the ECM 
architecture. In contrast, the granulomas in the 
lung samples obtained from the patients with 
pulmonary sarcoidosis showed distortions of 
the ECM architecture, as well as a strong and 
heterogeneous birefringence. Large, sparse, and 
fragmented bundles of elastic fibers were more 
commonly observed in the granulomas in the 
extrapulmonary samples than in those in the 
lung samples. This correlates with the epithelioid 
and sclerosing areas seen in H&E preparations.
Table 2 shows the measurements of collagen 
and elastic fibers in the pulmonary and 
extrapulmonary granulomas. The morphological 
changes in the collagen and elastic fibers coincided 
with the variations in quantity and density in 
the two fiber systems. Pulmonary granulomas 
showed a significantly higher number of collagen 
fibers and a lower density of elastic fibers than 
did extrapulmonary granulomas (p = 0.01 and 
p = 0.003, respectively), pulmonary sarcoidosis 
being therefore characterized by fibroelastosis.
Figure 2 shows the immune cells in the 
pulmonary and extrapulmonary granulomas stained 
by immunohistochemistry; the most common cells 
around the granulomas found in the patients 
with extrapulmonary sarcoidosis were as follows: 
CD3+, CD4+, and CD8+ T-lineage cells; CD20+ 
lymphocytes; elastase-positive neutrophils; and 
CD68+ macrophages.
Table 2 shows the quantification of immune 
cells in the pulmonary and extrapulmonary 
granulomas. The morphological distribution of 
the immune cells in the granulomas coincided with 
the differences in quantification between the two 
forms of sarcoidosis. Overall, the extrapulmonary 
sarcoidosis samples showed a significantly higher 
density of CD4+ lymphocytes (p = 0.001), CD8+ 
lymphocytes (p = 0.001), CD3+ lymphocytes 
(p = 0.001), CD68+ lymphocytes (p = 0.03), 
and elastase-positive neutrophils (p = 0.001) 
surrounding or permeating granulomatous 
structures than did the pulmonary sarcoidosis 
samples. The number of CD4+ lymphocytes was 
significantly higher in the granulomas in the lymph 
node samples than in those in the liver (p = 0.05), 
skin (p = 0.03), and lung samples (p = 0.001). 
In addition, the number of CD8+ lymphocytes 
surrounding granulomas was significantly higher 
in lymph node samples than in lung and skin 
samples (p = 0.001 and p = 0.003, respectively). 
Furthermore, the number of CD8+ lymphocytes 
was significantly higher in liver samples than in 
lung samples (p = 0.01). Granulomas in the lymph 
nodes also showed a higher number of CD3+, 
CD20+, and CD68+ lymphocytes than did those 
in the lungs (p = 0.001, p = 0.01, and p = 0.004, 
respectively). The number of CD1a+ cells was 
higher in the granulomas found in the skin than 
in those found in the lungs, lymph nodes, and 
liver (p = 0.001 for all). The number of elastase-
positive neutrophils permeating granulomas was 
higher in the liver than in the lungs (p = 0.02). 
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Figure 2 - Microscopic images of CD3+, CD4+, and CD8+ T lymphocytes; CD20+ B cells; CD68+ macrophages; 
CD1a+ dendritic cells; S100+ dendritic cells; and elastase-positive neutrophils in samples of lung, lymph 
node, liver, and skin parenchyma. It seems that CD4+ and CD8+ T lymphocytes are the most common cells 
infiltrating the lymph nodes, liver, skin, and lung. The lymph nodes also showed a significant number of CD3+, 
CD20+, and CD68+ cells. CD1a+ cells were most common in the skin, whereas elastase-positive neutrophils 
were prominent in the liver. The number of S100+ cells was similar in all the organs (immunohistochemical 
staining; magnification, ×400).
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term pulmonary function and will prevent the 
cumulative morbidity associated with the currently 
available therapy. The question of interest is 
whether further information can help us define 
the immune response and tissue remodeling 
in sarcoidosis on the basis of the histological 
characteristics and patterns of the granulomas, 
which will show a better correlation with pulmonary 
function tests and the natural history of the 
disease, as well as with the response to therapy. 
The pathological process in the granulomatous 
involvement in sarcoidosis undoubtedly includes 
complex serial and sequential steps; among these, 
severe immune dysfunction and tissue remodeling 
are thought to be important, given that both 
lead to scarring.(10)
The present study showed a higher degree 
of immunoreactivity to CD4, CD8, CD3, CD68, 
and neutrophils in extrapulmonary sarcoidosis 
than in pulmonary sarcoidosis. In addition, the 
number of CD4, CD8, CD3, and CD20 lymphocytes 
was significantly higher in the lymph node 
granulomas, whereas CD1a dendritic cells and 
neutrophils were more prominent in the skin and 
lung granulomas, respectively. It is known that 
CD4+ T lymphocytes play an essential role in 
creating the microenvironment for B lymphocyte 
activation and differentiation following antigen 
exposure. In the lungs, the fact that follicular 
B lymphocyte aggregates are located almost 
exclusively in peribronchiolar areas beneath the 
epithelium of the bronchial branches suggests 
that they represent the development of bronchus-
associated lymphoid tissue. These structures 
have been shown to be capable of mounting 
competent adaptive immune responses.(24) Unlike 
typical lymph nodes, they are not dependent 
on afferent lymphatics for antigen retrieval; 
rather, they sample antigen directly from the 
lung lumen. This raises the question of whether 
an external factor could promote the formation 
of lymphoid follicles in sarcoidosis, thereby 
inducing or modulating the disease process. 
This question is especially interesting in light 
of the reported association between smoking 
and increased formation of peribronchiolar B 
cell follicles in some pulmonary diseases.(25) 
Although CD4+ and CD8+ T lymphocytes are 
usually present in very low numbers in peripheral 
blood, increased numbers have been reported 
in apparently healthy individuals, as well as in 
various clinical conditions. In a recent study, 
The quantity of S100+ cells was very similar in 
the granulomas in the various organs studied.
Positive associations were found between CD4+ 
and CD8+ cells (r = 0.55; p = 0.001), between CD8+ 
cells and elastase-positive neutrophils (r = 0.34; 
p = 0.03), between CD8+ cells and elastic fibers 
(r = 0.41; p = 0.01), between CD3+ cells and 
elastic fibers (r = 0.46; p = 0.004), between CD1a+ 
cells and collagen fibers (r = 0.35; p = 0.05), and 
between elastase-positive neutrophils and elastic 
fibers (r = 0.35; p = 0.03). Negative associations 
were found between CD8+ cells and collagen 
fibers (r = −0.46; p = 0.04), as well as between 
CD1a+ cells and elastic fibers (r = −0.34; p = 0.05).
The cellular immune components and reparative 
components correlated with clinical, radiological, 
and pulmonary function findings in the patients 
with pulmonary sarcoidosis. We found that CD4+ 
lymphocytes were negatively associated with 
smoking history (r = −0.73; p = 0.03), radiological 
opacities (r = −0.59; p = 0.04), and micronodules 
(r = −0.54; p = 0.04). Mediastinal lymph node 
granulomas were positively associated with CD8+ 
lymphocytes (r = 0.70; p = 0.004). An FVC of 70% 
of the predicted value was positively associated 
with CD68+ macrophages (p < 0.05). The FEV1/
FVC ratio was positively associated with CD4+, 
CD8+, and CD3+ lymphocytes. A TLC of 82% 
of the predicted value was negatively associated 
with CD1a+ cells (p < 0.05). Finally, there was a 
negative association between DLCO and collagen/
elastic fibers (r = −0.90; p = 0.04).
Discussion
The pathological hallmark of sarcoidosis is the 
presence of noncaseating granulomas in various 
organs, including the lungs, lymph nodes, liver, 
skin, heart, and brain.(22) In this chronic systemic 
disease, these histologically compact inflammatory 
lesions containing T lymphocytes and mononuclear 
phagocytes can appear and disappear insidiously 
in some patients, whereas, in others, the lesions 
can cause significant organ dysfunction due to 
persistent inflammation and obliteration of vital 
structures, resulting in extensive tissue fibrosis or 
cavitation.(10) The most common and devastating 
effects occur in the pulmonary system.(23) Therefore, 
the knowledge of ECM remodeling and immune 
response mechanisms in the pathogenesis of 
sarcoidosis, together with the early detection of 
the disease by methods that are more sensitive 
and aimed at therapy, will help improve long-
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Moller et al. reported finding dominant Th1 
cytokine expression, with elevated mRNA and 
protein levels of IL-12 and IFN-γ, but not IL-4, 
in sarcoid lung cells when compared with those 
in normal samples,(26) supporting the notion of an 
exaggerated immunological/inflammatory response.
(27) Consistent with these findings, various other 
immunological abnormalities have been identified, 
including tissue accumulation of CD4+ cells with 
helper-inducer activity, increased in situ production 
of cell-derived cytokines, B cell hyperactivity with 
spontaneous production of immunoglobulins, and 
accumulation of activated monocytic cells. These 
cells are known to play key roles in active tissue 
remodeling by releasing soluble mediators, such as 
cytokines and chemokines with proinflammatory 
and fibrogenic activity, reactive oxygen species, 
and proteolytic enzymes that have the capacity 
to degrade the connective tissue scaffold.(10)
In our study, the granulomas in the samples 
obtained from patients with extrapulmonary 
sarcoidosis (lymph node, liver, and skin 
involvement) were found to be the prototype 
of the apposition of elastic fibers in the tissues. 
In contrast, the granulomas in the lung samples 
from patients with pulmonary sarcoidosis were 
found to represent the prototype of an increased 
number of collagen fibers and a lower degree of 
elastic apposition, characterizing a fibroelastotic 
process. The elastic system plays an important 
role in maintaining organ patency and the elastic 
recoil; therefore, elastosis might be important 
for the understanding of organ function.(11,12,28) 
Similar findings were reported by our group when 
studying the ECM in lung biopsy specimens from 
patients with idiopathic interstitial pneumonia.
(13,14) We hypothesized that elastosis is related to 
the inflammatory elastolysis observed at the initial 
stage of inflammation, reinforcing the notion 
that a proinflammatory mechanism is present in 
granulomatous diseases. The proinflammatory 
hypothesis is defended by various authors as 
a transient form of organizing fibrosis,(29) and 
some of our findings in the present study seem 
to support this theory, given that the highest 
levels of neutrophils were observed in the patients 
with pulmonary sarcoidosis.
For all of these reasons, it would not be 
surprising to learn that cell immunostaining 
and the determination of collagen/elastic fiber 
density can provide relevant information on tissue 
remodeling in sarcoidosis. Our results confirm 
the pathogenetic implications of immune cell 
infiltration and the remodeling state of granulomas 
in pulmonary and extrapulmonary sarcoidosis. 
Although only a few studies focusing on the 
production of matrix proteins, TGF-β, fibrin, and 
matrix metalloproteinases were able to demonstrate 
a significant association between tissue remodeling 
and immune response in sarcoidosis,(10,30) our results 
suggest that a fibroelastotic process, together with 
immune cell infiltration, probably contributes to 
tissue changes in sarcoidosis. More interestingly, 
our results suggest that antigen clearance is 
less efficient in pulmonary sarcoidosis than in 
extrapulmonary sarcoidosis. More specifically, we 
found that different functional tests corroborated 
the remodeling and immune cell regulation in 
pulmonary sarcoidosis, which is suggestive of a 
reparative effect on the functional and structural 
disarray found in the lung parenchyma.
The major limitations of the present study 
are related to the difficulty in comparing our 
results with those of other studies, given that 
there are few studies in the literature showing 
associations of immunophenotyping and tissue 
remodeling with standard clinical parameters 
(age, gender, smoking history, and duration of 
symptoms prior to lung biopsy), physiological 
tests, and dyspnea scores in sarcoidosis patients.
In summary, we have demonstrated the 
pathophysiological features of tissue remodeling 
and immune response in sarcoidosis. Particularly 
in pulmonary sarcoidosis, there are two different 
immune response and tissue remodeling pathways, 
with an impact on physiological tests. The immune 
and fibroelastotic processes observed in the 
parenchyma of the affected organs appear to 
be part of the general processes of inflammation 
and collagen/elastic fiber deposition, which have 
an independent course in sarcoidosis. Our findings 
suggest that there are two mechanisms of injury 
and repair in sarcoidosis, direct airway injury being 
more likely to occur in pulmonary sarcoidosis. 
Regardless of the pathogenetic determinants, the 
pathway involvement that is likely to progress 
to uncontrolled fibrosis and therefore shorten 
the life of patients with sarcoidosis should be 
identified so that the treatment is effective.
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